[D-Lys3]-GHRP-6
Sipariş numarası: C6472.0005
Shipping: shipped at RT, stored at -20°CCAS-Nr: 136054-22-3
Bugün gönderilmek için hazır,
Teslim süresi yaklaşık olarak 1-3 iş günü
| Miktar | Birim fiyatı |
|---|---|
| Hedef 2 | 132,61 € * |
| Kaynak 3 | 119,36 € * |
Fiyatlar artı KDV artı nakliye maliyetleri
[D-Lys3]-GHRP6 (growth hormone releasing peptide 6) induces the secretion of growth hormone (GH). In the membrane of clonal GC somatotropes, this peptide elevates the number of functional voltage-gated Ca2+ and Na+ channels. Chronic treatment with this peptide causes an elevation in Na+ macroscopic current in bovine pituitary somatotropes in culture, which results in an increase in the release of GH.
GH-releasing peptides (GHRPs) are synthetic peptides that like GHRH act directly on pituitary somatotrophs to stimulate GH release. Growth hormone (GH) release is stimulated by a variety of synthetic secretagogues, of which growth hormone-releasing hexapeptide (GHRP-6) has been most thoroughly studied, it is thought to have actions at both pituitary and hypothalamic site.
Synonyms: GHRP-6, GHRP, [D-Lys3]-GHRP-6.
Selective inhibitor of α-MSH activity in frog skin bioassay. Selectively releases growth hormone in vitro and in vivo. Somatostatin antagonist.
Technische Daten:
Specifications:
Purity: >98.0% (RP-HPLC)
Sequence:: HwAWfK-NH2 (TFA salt)
Sequence (three letter code): H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Appearance: white powder
Solution (1mg/mL): Clear and colourless
C49H63N13O6
MW = 930.1 g/mol
Applikation:
D-Lys3]-GHRP6 has been used • to treat bovine somatotropes to determine the release of GH from treated cells and non-treated or control cells. • for intraperitoneal injection to groups of broiler chicken to determine the effect on feed intake, weight gainQuelle
chemical synthesisSicherheits Hinweise / Safety
Klassifizierungen / Classification
CAS-Nr: 136054-22-3eclass-Nr: 34-16-04-90
Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu [D-Lys3]-GHRP-6. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.
